The technology is designed to improve surgical precision, shorten operating times, reduce blood loss, and accelerate recovery for patients with severe scoliosis and other spinal deformities.
Through its collaboration with Al Borg Diagnostics, members can schedule laboratory tests at home, reducing the need to visit healthcare facilities while encouraging earlier diagnosis and routine health monitoring.
The hospital successfully conducted two total hip replacement procedures in a carefully planned three-hour operation led by a multidisciplinary team of specialists.
The Phase 1 study forms part of an expanded collaboration between Moderna and the Coalition for Epidemic Preparedness Innovations (CEPI).
Its educational programs cover pediatric dentistry, airway health, sleep-disordered breathing, oral function, early facial growth, interceptive orthodontics and myofunctional therapy.
The government gazetted the new status on July 24, 2026, marking a significant step in the development of specialised infectious disease services, research and training in the country.
The test could also help clinicians identify patients who are unlikely to benefit from immunotherapy before treatment begins, potentially allowing them to consider alternative therapies sooner.
The partnership will unlock KSh10.4 billion (US$80 million) over the next five years to accelerate implementation of Kenya’s Every Woman Every Newborn Everywhere (EWENE) Acceleration Plan and support the country’s 90-90-80-80 maternal and newborn health targets.
The expanded role is expected to strengthen referral services across Western Kenya and the wider East African region while reducing pressure on national referral hospitals.
The clinical trial will assess SIL204, an investigational treatment developed by Silexion using small interfering RNA (siRNA) technology.